ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SHARI MANN M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,602Medicare Part D Prescriptions Filled, Including Refills

Rank: 352 out of 5176

$1,657 Total Retail Price of All Prescriptions

Rank: 5166 out of 5176

212 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 212 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 212 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 11,890 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$0 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

59 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
ASPIRIN EC 379 379 1 190
VITAMIN D2 319 316 2 214
ONCE DAILY 292 276 10 3 327
AMLODIPINE BESYLATE 260 240 4 2
ATORVASTATIN CALCIUM 259 246 5 9
OMEPRAZOLE 256 253 6 3
DOCUSIL 251 249 10 7 344
FUROSEMIDE 218 200 8 8
SENNO 207 207 10 9 371
SIMVASTATIN 197 189 10 1
JANUVIA 191 191 11 25
ALENDRONATE SODIUM 177 171 12 18
OYSTER SHELL CALCIUM W-VIT D 175 166 13 308
METOPROLOL SUCCINATE 162 161 14 11
METOPROLOL TARTRATE 150 138 15 6
HYDROCHLOROTHIAZIDE 147 143 16 10
METFORMIN HCL 146 146 17 7
TAMSULOSIN HCL 141 140 18 20
COUMADIN 140 128 19 112
FOLIC ACID 127 125 20 392
TACTINAL 122 122 10 21 433
PAIN RELIEVER 122 112 21 501
DONEPEZIL HCL 120 120 23 28
LISINOPRIL 118 118 24 5
LOSARTAN POTASSIUM 113 106 25 14
GLIMEPIRIDE 109 107 26 37
POLYETHYLENE GLYCOL 3350 109 108 26 74
ISOSORBIDE MONONITRATE ER 108 108 28 44
PANTOPRAZOLE SODIUM 107 83 29 61
FERROUS SULFATE 98 86 30 351
LEVOTHYROXINE SODIUM 97 97 31 4
NEXIUM 97 77 31 16
FOSINOPRIL SODIUM 87 87 33 105
GABAPENTIN 85 84 34 21
ATENOLOL 84 75 35 12
CRESTOR 80 79 36 15
CLOPIDOGREL 79 73 37 26
DOCUSATE SODIUM 78 63 38 286
LANTUS SOLOSTAR 75 74 39 70
SILTUSSIN DM DAS COUGH FORMULA 74 74 10 40 637
ARTIFICIAL TEARS 74 61 40 369
MULTIVITAMINS 71 64 42 335
ACETAMINOPHEN-CODEINE 69 65 S3 43 127
LUNESTA 68 68 44 242
CALCIUM 68 68 44 417
ENALAPRIL MALEATE 68 68 44 22
LANTUS 64 64 47 66
CENTRUM SILVER 64 64 47 662
ESCITALOPRAM OXALATE 63 63 49 89
LACLOTION 62 62 50 299
INSULIN SYRINGE 60 60 51 137
PLAVIX 60 54 51 29
POTASSIUM CHLORIDE 59 47 53 34
NIFEDICAL XL 59 59 53 174
MIRTAZAPINE 59 59 53 45
ZOLPIDEM TARTRATE 58 47 56 17
FINASTERIDE 57 57 57 69
CLONAZEPAM 56 56 58 689
ALBUTEROL SULFATE 56 56 58 99
PROAIR HFA 56 55 58 60
SENNA-GEN 55 44 61 337
VITAMIN D 54 53 62 298
HUMALOG 54 54 62 245
LATANOPROST 53 53 64 185
RISPERIDONE 51 51 65 78
GLYBURIDE 51 42 R 65 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.